These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Treatment of coronary insufficiency with beta receptor blocking agents]. Wink K Med Monatsschr; 1975 Feb; 29(2):65-7. PubMed ID: 236488 [No Abstract] [Full Text] [Related]
4. [Metabolic effects of various palliative drugs for coronary insufficiency]. Deltour G Therapie; 1970; 25(2):293-322. PubMed ID: 4404034 [No Abstract] [Full Text] [Related]
5. [Coronary dilators]. Ilic-Vukotić M Med Arh; 1972; 26(2):81-4. PubMed ID: 4402269 [No Abstract] [Full Text] [Related]
6. [Effect of different groups of adrenergic beta receptor blockaders on the clinical course of the disease, work capacity and echocardiographic indicators in ischemic heart disease]. Komarov FI; Ol'binskaia LI; Bragina GI Ter Arkh; 1979; 51(8):13-7. PubMed ID: 41333 [No Abstract] [Full Text] [Related]
7. Pharmacological approaches to the therapy of angina. Parratt JR Adv Drug Res; 1974; 9():103-34. PubMed ID: 4156950 [No Abstract] [Full Text] [Related]
8. Effects of beta-adrenoceptor blocking agents on haemodynamic parameters. Hansson L Acta Med Scand Suppl; 1977; 606():49-54. PubMed ID: 19930 [No Abstract] [Full Text] [Related]
10. [Effect of Fendilin on the exercise test in patients with coronary disease]. Spiel R; Enenkel W Wien Med Wochenschr; 1976 Mar; 126(13-14):186-9. PubMed ID: 10680 [No Abstract] [Full Text] [Related]
11. [Effect of beta-blockaders on coronary output: study in humans using xenon- 133 ]. Lichtlen P; Albert H; Moccetti T Therapie; 1970; 25(2):403-8. PubMed ID: 4403160 [No Abstract] [Full Text] [Related]
13. Pathophysiology of myocardial ischaemia and the prevention of necrosis. Taylor RR Clin Exp Pharmacol Physiol Suppl; 1982; 6():67-74. PubMed ID: 6126288 [No Abstract] [Full Text] [Related]
14. Comparative profile of L 3428 and other antianginal agents on cardiac hemodynamics. Petta JM; Zaccheo VJ J Pharmacol Exp Ther; 1971 Feb; 176(2):328-38. PubMed ID: 4998691 [No Abstract] [Full Text] [Related]
15. [Symposium on problems in the clinical pharmacology of coronary dilators. Introduction]. Holtz P Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1969; 263(1):121-7. PubMed ID: 4308585 [No Abstract] [Full Text] [Related]
16. [Effect of pindolol on myocardial blood supply, metabolism and function at rest and under frequency stimulation in patients with coronary disease]. Kupper W; Hamm C; Bleifeld W; Hanrath P; Mathey D Verh Dtsch Ges Inn Med; 1978; (84):1530-2. PubMed ID: 742007 [No Abstract] [Full Text] [Related]
17. [Effects of nitrates and beta-blockers on platelet aggregation in patients with coronary heart disease]. Wlazłowski R; Kruszyński G; Goch JH Pol Merkur Lekarski; 2000 Feb; 8(44):77-9. PubMed ID: 10808734 [TBL] [Abstract][Full Text] [Related]
18. [Treatment of coronary circulatory disorders]. Reploh HD Med Welt; 1971 Oct; 44():1727-32. PubMed ID: 4399460 [No Abstract] [Full Text] [Related]
19. [Effects of nitroglycerin on exercise hemodynamics in patients with coronary heart disease under treatment with beta-blockers (mepindolol, oxprenolol) and a calcium-antagonist (fendiline) (author's transl)]. Reiterer W Wien Med Wochenschr; 1980 Dec; 130(23):772-7. PubMed ID: 6111161 [TBL] [Abstract][Full Text] [Related]